Carranza-Lira S, Cabrera-López TJ, Estrada-Moscoso I, Aguado-Pérez RA

Language: Spanish
References: 15
Page: 315-318
PDF size: 28.27 Kb.

ABSTRACT

Background: local estrogen treatments have been used for vaginal dryness management. The objective was to determine the maturation index (MI) and vaginal dryness after the treatment with topic conjugated estrogens (TCE) in low and conventional doses in Mexican women.
Methods: postmenopausal women that received vaginal TCE cream. Group I Low-dose which received 0.5 g of TCE twice a week and Group II Conventional-dose with one g of TCE twice a week. The MI was determined and estrogenic value (EV) was calculated. Vaginal dryness was evaluated with an analog visual scale, and vaginal humidity by the moistening of a pH test strip measured in millimeters. Statistical analysis with Student’s t test for independent and paired samples was done.
Results: 27 women were studied, group I (n = 13), group II (n = 14). There weren’t any differences in the analyzed parameters. Both treatments increased the MI and decreased the vaginal dryness.
Conclusions: low and conventional dose of TCE had similar effect in vaginal ambit in Mexican women.

REFERENCES

1. Stenberg A, Heuimer G, Ulmesten U, Cnattingius S. Prevalence of genitourinary and other climacteric symptoms in 61 year-old women. Maturitas 1996;24(1-2):31-36.

2. Bachmann GA, Nevadunsky NS. Diagnosis and treatment of atrophic vaginitis. Am Fam Physician 2000;61(10):3090- 3096. Disponible en http://www.aafp.org/link_out?pmid=10839558

3. Jones HW, Jones GS. Tratado de ginecología de Novak. Décima edición. México: McGraw-Hill Interamericana; 1984.

4. Brizzolara S, Killeen J, Severino R. Vaginal pH and parabasal cells in postmenopausal women. Obstet Gynecol 1999;94 (5 Pt 1):700-703.

5. Carranza-Lira S, Fragoso-Díaz N, MacGregor-Gooch AL, Garduño-Hernández MP, Ríos-Calderón K, et al. Vaginal dryness assessment in postmenopausal women using pH test strip. Maturitas 2003;45(1):55-58.

6. American College of Obstetricians and Gynecologists Women’s Health Care Physicians. Genitourinary tract changes. Obstet Gynecol 2004;104(4 Suppl):56S-61S.

7. Rioux JE, Devlin MC, Gelfand MM, Steinberg WF, Hepburn DS. 17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis. Menopause 2000;7(3):156-161.

8. Palacios S, Castelo-Branco C, Cancelo MJ, Vázquez F. Lowdose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormona therapy. Maturitas 2005;50(2):98-104.

9. Handa VL, Bachus KE, Johnston WW, Robboy SJ, Hammond CB. Vaginal administration of low-dose conjugated estrogens: systemic absorption and effects on the endometrium. Obstet Gynecol 1994;84(29):215-218.

10. Raymundo N, Yu-cheng B, Zi-yan H, Lai-CH, Leung K, Subramaniam R, et al. Treatment of atrophic vaginitis with topical conjugated equine estrogens in postmenopausal Asian women. Climacteric 2004;7(3):312-318.

11. Marx P, Schade G, Wilbourn S, Blank S, Moyer DL, Nett R. Low-dose (0.3 mg) synthetic conjugated estrogens A is effective for managing atrophic vaginitis. Maturitas 2004; 47(1):47-54.

12. Cardozo L, Bachmann G, McClish D, Fonda D, Birgerson L. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: Second Report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1998;92(4 Pt 2):722-727.

13. Carranza-Lira S, Barraza-Solorzano M, Fernández RL. Changes in vaginal cytology after various types of hormone replacement therapy, according to body mass index and body fat distribution in postmenopausal women. Int J Gynaecol Obstet 2002;78(2):167-169.

14. North American Menopause Society. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society. Menopause 2007;14(Pt 1): 355-369.

15. Palacios S. Managing urogenital atrophy. Maturitas 2009; 63(4):315-318.